Bai Jin Life Sciences (01466.HK) annual performance report released, shareholders' net loss was HK$316,000, a year-on-year decrease of 95.76%.

Zhixin Finance News APP reported that Baijin Life Science (01466.HK) announced its annual performance for the year ended March 31, 2025. The group achieved a revenue of 136 million Hong Kong dollars during the period, an increase of 152.54% year-on-year. The company's attributable loss was 316,000 Hong Kong dollars, a decrease of 95.76% year-on-year. The basic loss per share was 0.05 Hong Kong cents.